Wolfgang Schmitz

06.11.2015 • News

Saltigo to Invest €60 Million at Leverkusen

Lanxess is investing some €60 million in expanding custom synthesis facilities at multi-purpose production facilities in the Central Organics Pilot Plant (ZeTO) of fine chemicals subsidiary Saltigo in Leverkusen, Germany.

Photo
18.10.2012 • News

Saltigo Realigns Strategy

Saltigo, the custom manufacturing business of Lanxess' Advanced Intermediates segment, which achieved total sales of €1.5 billion in 2011, has realigned its strategy.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.